6550--Rapid Molecular Testing via Roche Diagnostics Corporation

Rapid Molecular Testing for SARS COV-2, Flu and STREP.

The purpose of this activity is to acquire Rapid Molecular Testing Supplies for the Pathology and Laboratory Medical Service at the Jonathan M Wainwright Memorial VA.

1. Maintain the use of the Rapid Molecular Test System, Reagents, and Service, for testing Clinical Laboratory specimens on a reagent rental agreement (Cost Per Test/Cost Per Reportable).
2. Provide, and Service for performing SARS CoV-2,  Influenza A/B and Strep Group A on a base year plus four (4) option years fixed price contract.